Replies to post #131788 on Anavex Life Sciences Corp (AVXL)

[Steady_T]

Because it is another step towards approval. It requires FDA to bless the previous data and that confers some additional legitimacy. Further, if the trial design is under the newly created rules, it suggests that the FDA has some degree of faith in the outcome.

When all three trials get started, the odds of success go up significantly, since success on any one trial will lead to an approved drug.That will confer additional legitimacy on the other trials in progress.

Forward progress counts.

[scottsmith]

I agree. The big money made in anavex comes in two spots: one past and one future. The past, as we know, was buying before the R/S split. The future big money will only come after the next successful trial not simply the start of a trial.

[Amatuer17]

I am not sure it will be a rally but a one time bump - to readjust the baseline - maybe around $5

The trial start will indicate that co is progressing and doing actual work than just talking.

Also - Rett trial itself is short duration - 4+12 =16 weeks and not like 12 months for Alz

This means if they do enrollment at right speed we can possibly see topline results by end of 2018

If the results are spectacular - we can move product forward fast and it will give confidence that drug may work on other CNS indications such as PD and AD

So all this optimism will really give the one time bump - and the visibility may bring 1st time investors creating additional demand to support the higher baseline price.

[Kentucky123]

I appreciate your work and would be interested in your study forum. Where is it located?
Right now AVXL is oversold and is due for a bounce. The Bollinger bands are in a squeeze on the monthly, weekly and daily.